• Natural Alternatives International posted a wider FY26 net loss of USD 20.7 million while net sales rose 10% to USD 142.52 million.
• Loss from operations widened to USD 18.75 million, and the results included a USD 10.41 million non-cash impairment loss.
• Private-label contract manufacturing net sales increased 11% to USD 134.62 million, while patent and trademark licensing net sales fell to USD 7.9 million.
• Net cash used in operating activities was USD 8.9 million, and cash, cash equivalents and restricted cash totaled USD 7.5 million at June 30, 2026.
• Management expects a net loss in FY27 and flagged substantial doubt about going concern tied to covenant compliance risk.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NAI - Natural Alternatives International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-031343), on September 28, 2026, and is solely responsible for the information contained therein.